Hong Kong Stock Exchange

Addentax Group Corp. and Regina Miracle International (Holdings) Limited Entered into a Collaboration Agreement to Enhance Textile and Garment Industry Services

Retrieved on: 
Tuesday, March 5, 2024

Regina is a global leading manufacturer of intimate apparel, renowned for its unique Innovative Design Manufacturing ("IDM") business model.

Key Points: 
  • Regina is a global leading manufacturer of intimate apparel, renowned for its unique Innovative Design Manufacturing ("IDM") business model.
  • Addentax and Regina have entered into a collaboration agreement aimed at producing high-quality, functional, and fashionable activewear.
  • This agreement leverages upon Addentax's strong manufacturing capabilities and comprehensive industry chain services with Regina's advanced research and development technology in sportswear industry.
  • According to the agreement, Regina will provide its IDM business model to enhance Addentax's activewear division.

Trip.com Group Limited Reports Unaudited Fourth Quarter and Full Year of 2023 Financial Results

Retrieved on: 
Wednesday, February 21, 2024

For the fourth quarter of 2023, Trip.com Group reported net revenue of RMB10.3 billion (US$1.5 billion), representing a 105% increase from the same period in 2022 primarily due to substantial recovery of travel market.

Key Points: 
  • For the fourth quarter of 2023, Trip.com Group reported net revenue of RMB10.3 billion (US$1.5 billion), representing a 105% increase from the same period in 2022 primarily due to substantial recovery of travel market.
  • Net revenue for the fourth quarter of 2023 decreased by 25% from the previous quarter, primarily due to seasonality.
  • Accommodation reservation revenue for the fourth quarter of 2023 decreased by 30% from the previous quarter, primarily due to seasonality.
  • Adjusted EBITDA margin was 28% for the fourth quarter of 2023, compared to 6% for the same period in 2022 and 34% for the previous quarter.

Snom Amplifies Partner Success with New “Save With Snom” Deal Registration Program

Retrieved on: 
Thursday, February 15, 2024

Snom America will introduce the launch of its “Save With Snom” Deal Registration Program, a game-changer for MSPs and resellers looking to elevate their market position.

Key Points: 
  • Snom America will introduce the launch of its “Save With Snom” Deal Registration Program, a game-changer for MSPs and resellers looking to elevate their market position.
  • "Snom Americas is committed to driving partner growth," said Marc Magliano, Vice President, Channel Business for the Americas for Snom Americas.
  • "Our Save With Snom Deal Registration Program is more than just a discount; it's a strategic move to streamline success for our distributors and resellers."
  • The Save With Snom Deal Registration Program is another example of Snom America's innovative approach, ensuring that distribution partners and their customers enjoy a smooth transaction and a tangible competitive edge.

China Power (02380): High-Quality Stock in the Power Sector, with SPIC Continuously Increasing Its Stake to 64.01%

Retrieved on: 
Thursday, January 25, 2024

SPIC is fully optimistic about the future development of China Power.

Key Points: 
  • SPIC is fully optimistic about the future development of China Power.
  • With the support of SIPC, China Power has become a benchmark for the transformation of the power industry.
  • In the future, SPIC may continue to inject its clean energy into its listed platforms, enabling China Power to continue to lead the new energy power industry.
  • For example, in the case of China Power, its major shareholder, SPIC, has responded quickly, reflecting the spirit of responsibility of central state-owned enterprises.

Founder Securities rates Baguio (1397.HK) as 'Strongly Recommended' with a HK$1.10 target price, indicating a 57% upside

Retrieved on: 
Tuesday, January 2, 2024

This target suggests a potential 57% increase from the closing price on the date of the report.

Key Points: 
  • This target suggests a potential 57% increase from the closing price on the date of the report.
  • Founder Securities is optimistic about the Company's prospects as it will directly benefit from the implementation of the policy.
  • According to Founder Securities, the Company has a competitive edge and has been rapidly gaining government contracts in the past three years.
  • Based on 8 times target P/E ratio and 2024 earnings, Founder Securities rates Baguio as 'Strongly Recommended', with a target price of HK$1.10.

H World Group Limited Schedules Third Quarter of 2023 Earnings Release on November 24, 2023

Retrieved on: 
Friday, November 10, 2023

H World’s management will host a conference call at 8 p.m. (U.S. Eastern time) on Sunday, November 26, 2023 (or 9 a.m. (Hong Kong time) on Monday, November 27, 2023) following the announcement.

Key Points: 
  • H World’s management will host a conference call at 8 p.m. (U.S. Eastern time) on Sunday, November 26, 2023 (or 9 a.m. (Hong Kong time) on Monday, November 27, 2023) following the announcement.
  • To join by phone, all participants must pre-register this conference call using the Participant Registration link of https://s1.c-conf.com/diamondpass/10034960-g8sm4f.html .
  • Upon registration, each participant will receive details for the conference call, including dial-in numbers, conference call passcode and a unique access PIN.
  • A replay of the conference call will be available for twelve months from the date of the conference at the Company’s website, https://ir.hworld.com/news-and-events/events-calendar .

InnoCare Appoints Xin Fu as Chief Financial Officer

Retrieved on: 
Monday, December 18, 2023

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced today that the Company appointed Mr. Xin Fu, who has extensive finance-related experience, as the Chief Financial Officer (CFO).

Key Points: 
  • InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced today that the Company appointed Mr. Xin Fu, who has extensive finance-related experience, as the Chief Financial Officer (CFO).
  • Mr. Fu has over 20 years of financial management experience, including 15 years in the healthcare industry.
  • Before joining InnoCare, Mr. Fu served as the Chief Financial Officer at JW Therapeutics, where he played a critical role in the completion the of IPO in the Hong Kong Stock Exchange, company strategy planning, investment and financing activities, etc.
  • Prior to JW Therapeutics, Mr. Fu held multiple leadership positions at Pfizer China, including Chief Financial Officer and Chief Compliance Officer.

Graphite for North America Graphex Group Receives Unsolicited Preliminary Offer and LOI to Buy Graphex Technologies and Propel its North American Expansion Strategy

Retrieved on: 
Wednesday, December 6, 2023

The consideration for the Acquisition will be paid by the Purchaser solely in shares of its common stock (“Consideration Shares”).

Key Points: 
  • The consideration for the Acquisition will be paid by the Purchaser solely in shares of its common stock (“Consideration Shares”).
  • The final consideration will be determined in the definitive agreement to be entered into by both parties after further negotiations.
  • However, there can be no assurance that the Acquisition will be completed on acceptable terms or at all.
  • As soon as practicable upon the completion of the Acquisition, Graphex Group intends to distribute the Consideration Shares to all its shareholders on a pro rata basis.

Innovent's MSCI ESG Rating Upgraded to A

Retrieved on: 
Thursday, November 30, 2023

The MSCI ESG rating is one of the ESG indicators widely recognized by the global capital market.

Key Points: 
  • The MSCI ESG rating is one of the ESG indicators widely recognized by the global capital market.
  • According to MSCI's latest ESG rating report, Innovent's performance in ESG and sustainable development stood out above the industry average level.
  • The rating upgradation to level 'A' reflects the capital market's recognition of Innovent's continued progress in ESG governance and sustainability, as well as of its long-term investment value.
  • The ESG governance of Innovent is directly managed at the Board of Directors level and supervised by the Audit Committee.

Trip.com Group Limited Reports Unaudited Third Quarter of 2023 Financial Results

Retrieved on: 
Wednesday, November 22, 2023

SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961) ("Trip.com Group" or the "Company"), a leading one-stop travel service provider of accommodation reservation, transportation ticketing, packaged tours, and corporate travel management, today announced its unaudited financial results for the third quarter of 2023.

Key Points: 
  • SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961) ("Trip.com Group" or the "Company"), a leading one-stop travel service provider of accommodation reservation, transportation ticketing, packaged tours, and corporate travel management, today announced its unaudited financial results for the third quarter of 2023.
  • "Throughout the third quarter of 2023, both domestic and international travel experienced a remarkable rebound, thanks to the robust summer travel demands.
  • Net revenue for the third quarter of 2023 increased by 22% from the previous quarter, primarily due to seasonality.
  • Accommodation reservation revenue for the third quarter of 2023 increased by 30% from the previous quarter, primarily due to seasonality.